Biogen's (BIIB +0.9%) Tecfidera may be stealing some thunder from Novartis' (NVS -0.6%) Gilenya,...

|About: Biogen Inc. (BIIB)|By:, SA News Editor

Biogen's (BIIB +0.9%) Tecfidera may be stealing some thunder from Novartis' (NVS -0.6%) Gilenya, Wells Fargo's Brian Abrahams says, noting that U.S. Gilenya sales came in at $255M for Q2 (from slide 37 of the Q2 presentation) representing just 5% Q/Q growth compared to a historical average of 13%. Abrahams was out earlier this month with bullish commentary on Tecfidera's W/W sales growth.